This new knowledge is highly relevant for precision medicine in diabetes as a novel mechanism for HNF-1A regulation and altered function by PIASγ, which reveal potential new targets for drug development in HNF-1A associated diabetes. This evidence concerns the gene PIAS4 and diabetes mellitus.